{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:14:25Z","timestamp":1778728465326,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.phrs.2012.06.010","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T04:00:42Z","timestamp":1340942442000},"page":"283-291","source":"Crossref","is-referenced-by-count":10,"title":["Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: Positive association with stearoyl-CoA desaturase"],"prefix":"10.1016","volume":"66","author":[{"given":"Robert K.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Jack","family":"Magrisso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rylon","family":"Hofacer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Jandacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Tso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2012.06.010_bib0005","first-page":"18","article-title":"Weight gain with atypical antipsychotics: evidence and insights","volume":"68","author":"Henderson","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0010","first-page":"27","article-title":"Effects of atypical antipsychotics on weight and serum lipid levels","volume":"62","author":"Meyer","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0015","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.phrs.2012.06.010_bib0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0030","first-page":"13","article-title":"Trends in antipsychotic drug use by very young, privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jad.2009.10.023","article-title":"Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)","volume":"124","author":"Bond","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.phrs.2012.06.010_bib0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2012.06.010_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1399-5618.2010.00797.x","article-title":"Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses","volume":"12","author":"Moreno","year":"2010","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.phrs.2012.06.010_bib0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004583-200203000-00014","article-title":"Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study","volume":"41","author":"Ratzoni","year":"2002","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","article-title":"Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA\/APA recommendations for second-generation antipsychotic drugs","volume":"67","author":"Morrato","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2217\/clp.09.62","article-title":"Modulation of polyunsaturated fatty acid biosynthesis by antipsychotic medications: implications for the pathophysiology and treatment of schizophrenia","volume":"4","author":"McNamara","year":"2009","journal-title":"Clinical Lipidology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2146\/ajhp060164","article-title":"Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia","volume":"64","author":"McKenney","year":"2007","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1016\/j.phrs.2012.06.010_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1463-1326.2009.01130.x","article-title":"Dietary supplementation of n\u22123 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat","volume":"12","author":"Hassanali","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.phrs.2012.06.010_bib0075","first-page":"225","article-title":"Omega-3 fatty acid deficiency increases stearyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels","volume":"85","author":"Hofacer","year":"2011","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.phrs.2012.06.010_bib0080","first-page":"1","article-title":"Chronic dietary n\u22123 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome","volume":"31","author":"Lu","year":"2011","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.phrs.2012.06.010_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6793-8-21","article-title":"Hepatic steatosis in n\u22123 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition","volume":"8","author":"Pachikian","year":"2008","journal-title":"BMC Physiology"},{"issue":"8","key":"10.1016\/j.phrs.2012.06.010_bib0090","doi-asserted-by":"crossref","first-page":"e23365","DOI":"10.1371\/journal.pone.0023365","article-title":"Hepatic n\u22123 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets","volume":"6","author":"Pachikian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2012.06.010_bib0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clnu.2008.02.001","article-title":"Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles","volume":"27","author":"Qi","year":"2008","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.phrs.2012.06.010_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/oby.2007.518","article-title":"Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients","volume":"15","author":"Elizondo","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2012.06.010_bib0105","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.3109\/17477166.2010.549489","article-title":"Omega-3 index, obesity and insulin resistance in children","volume":"6","author":"Burrows","year":"2011","journal-title":"International Journal of Pediatric Obesity"},{"key":"10.1016\/j.phrs.2012.06.010_bib0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n\u22126\/n\u22123 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.phrs.2012.06.010_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2003.08.010","article-title":"Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment","volume":"69","author":"Evans","year":"2003","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.phrs.2012.06.010_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.phrs.2012.06.010_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0924-977X(02)00130-X","article-title":"Polyunsaturated fatty acid deficit in patients with bipolar mania","volume":"13","author":"Chiu","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11745-008-3224-z","article-title":"Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder","volume":"43","author":"Clayton","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2012.06.010_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2010.03.015","article-title":"Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder","volume":"126","author":"McNamara","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.phrs.2012.06.010_bib0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/j.1440-1614.2006.01869.x","article-title":"Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine","volume":"40","author":"Caniato","year":"2006","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1152\/ajpendo.90897.2008","article-title":"Biochemical and physiological function of stearoyl-CoA desaturase","volume":"297","author":"Paton","year":"2009","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.phrs.2012.06.010_bib0160","doi-asserted-by":"crossref","first-page":"30132","DOI":"10.1074\/jbc.M005488200","article-title":"The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1","volume":"275","author":"Miyazaki","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0165","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-2275(20)31589-3","article-title":"A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis","volume":"42","author":"Miyazaki","year":"2001","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0170","doi-asserted-by":"crossref","first-page":"25164","DOI":"10.1074\/jbc.M402781200","article-title":"Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms","volume":"279","author":"Miyazaki","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0175","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1073\/pnas.1934571100","article-title":"Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle","volume":"100","author":"Rahman","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2012.06.010_bib0180","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2012.06.010_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2009.07.004","article-title":"Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models","volume":"618","author":"Issandou","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bmcl.2009.10.101","article-title":"Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats","volume":"20","author":"Uto","year":"2010","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.phrs.2012.06.010_bib0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbalip.2008.12.011","article-title":"Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity","volume":"1791","author":"Flowers","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.phrs.2012.06.010_bib0200","doi-asserted-by":"crossref","first-page":"E321","DOI":"10.1152\/ajpendo.00306.2010","article-title":"Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans","volume":"300","author":"Peter","year":"2011","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.phrs.2012.06.010_bib0205","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1194\/jlr.M200189-JLR200","article-title":"Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia","volume":"43","author":"Attie","year":"2002","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","article-title":"Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?","volume":"5","author":"Fern\u00f8","year":"2005","journal-title":"Pharmacogenomics Journal"},{"key":"10.1016\/j.phrs.2012.06.010_bib0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2008.11.025","article-title":"Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia","volume":"108","author":"Polymeropoulos","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","article-title":"SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?","volume":"289","author":"Raeder","year":"2006","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2011.03.016","article-title":"Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity","volume":"129","author":"McNamara","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1461145708008468","article-title":"Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients","volume":"11","author":"Vik-Mo","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0245","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1006\/bbrc.1994.1516","article-title":"Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids","volume":"200","author":"Landschulz","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.phrs.2012.06.010_bib0250","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0005-2760(88)90262-7","article-title":"Dietary cholesterol and\/or n\u22123 fatty acid modulate delta 9-desaturase activity in rat liver microsomes","volume":"962","author":"Garg","year":"1988","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.phrs.2012.06.010_bib0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11745-011-3637-y","article-title":"Daily intake of cod or salmon for 2 weeks decreases the 18:1n\u22129\/18:0 ratio and serum triacylglycerols in healthy subjects","volume":"47","author":"Telle-Hansen","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2012.06.010_bib0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacl.2009.06.002","article-title":"Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: implications for the dietary management of elevated serum triglycerides","volume":"3","author":"Velliquette","year":"2009","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2008.09.027","article-title":"Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis","volume":"107","author":"McNamara","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/clinchem\/21.3.437","article-title":"A manual colormetric assay of triglycerides in serum","volume":"21","author":"Biggs","year":"1975","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.phrs.2012.06.010_bib0280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/87.4.817","article-title":"Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3d of high-carbohydrate feeding","volume":"87","author":"Chong","year":"2008","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.phrs.2012.06.010_bib0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S0029665107005290","article-title":"Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis","volume":"66","author":"Chong","year":"2007","journal-title":"Proceedings of the Nutrition Society"},{"key":"10.1016\/j.phrs.2012.06.010_bib0290","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI118645","article-title":"Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet","volume":"97","author":"Hudgins","year":"1996","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.phrs.2012.06.010_bib0295","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2144\/000112400","article-title":"Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays","volume":"42","author":"Cai","year":"2007","journal-title":"Biotechniques"},{"issue":"9","key":"10.1016\/j.phrs.2012.06.010_bib0300","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1371\/journal.pone.0000898","article-title":"Evidence based selection of housekeeping genes","volume":"2","author":"de Jonge","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2012.06.010_bib0305","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.phrs.2012.06.010_bib0315","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.psyneuen.2008.10.013","article-title":"Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition","volume":"34","author":"McNamara","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1440-1681.2005.04184.x","article-title":"Resistance to excessive bodyweight gain in risperidone-injected rats","volume":"32","author":"Ota","year":"2005","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human","volume":"75","author":"Pouzet","year":"2003","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.phrs.2012.06.010_bib0330","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","article-title":"Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration","volume":"46","author":"Minet-Ringuet","year":"2006","journal-title":"Appetite"},{"key":"10.1016\/j.phrs.2012.06.010_bib0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0269881106069637","article-title":"Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities","volume":"21","author":"Cooper","year":"2007","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0340","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","article-title":"Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions","volume":"28","author":"Birkenaes","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.phrs.2012.06.010_bib0345","first-page":"331","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1016\/j.phrs.2012.06.010_bib0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.plefa.2009.02.004","article-title":"Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat\/high-sucrose diet-fed mice","volume":"80","author":"Kajikawa","year":"2009","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.phrs.2012.06.010_bib0355","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.nutres.2011.08.007","article-title":"Omega-3 fatty acid deficiency selectively up-regulates delta6-desaturase expression and activity indices in rat liver: Prevention by normalization of omega-3 fatty acid status","volume":"31","author":"Hofacer","year":"2011","journal-title":"Nutrition Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2011.03.006","article-title":"Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: relationship with liver delta6-desaturase expression","volume":"129","author":"McNamara","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.phrs.2012.06.010_bib0365","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ijo.2008.89","article-title":"Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents","volume":"32","author":"Steffen","year":"2008","journal-title":"International Journal of Obesity (London)"},{"key":"10.1016\/j.phrs.2012.06.010_bib0370","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1742-7843.2007.00198.x","article-title":"Chronically administered risperidone did not change the number of hepatocytes in rats: a stereological and histopathological study","volume":"102","author":"Halici","year":"2008","journal-title":"Basic & Clinical Pharmacology & Toxicology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T21:24:21Z","timestamp":1642627461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661812001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1043661812001284"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.06.010","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}